For research use only
| Cat No. | ABC-TC3773 |
| Product Type | Pulmonary Cells |
| Cell Type | Fibroblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Pulmonary Artery |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Fibroblasts are mesenchymal cells which derived from the embryonic mesoderm.
| Product Code | Human Pulmonary Artery Adventitia Fibroblasts, Pulmonary Adventitial Fibroblasts, PAAF Cells, Pulmonary Artery Fibroblasts |
| Species | Human |
| Cat.No | ABC-TC3773 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Pulmonary Artery |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Pulmonary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Pulmonary Artery Adventitial Fibroblasts, also known as Human pulmonary artery adventitial fibroblasts (HPAAF), Primary lung artery adventitia cells, or human pulmonary stromal fibroblasts, are ideal for studies of pulmonary vascular remodeling, particularly in pulmonary hypertension, hypoxia-induced neovascularization, extracellular matrix deposition, redox-mediated signaling, and adventitial–endothelial crosstalk. They serve as a key cellular component in dissecting the fibrotic and inflammatory responses within the pulmonary arterial wall. They are valuable for testing anti-fibrotic therapies, angiogenesis inhibitors, and exploring fibroblast-driven vascular pathophysiology.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Davis-Hall D, Thomas E, Peña B, Magin CM. 3D-bioprinted, phototunable hydrogel models for studying adventitial fibroblast activation in pulmonary arterial hypertension. Biofabrication. 2022;15(1):10.1088/1758-5090/aca8cf. Published 2022 Dec 19. doi:10.1088/1758-5090/aca8cf